DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis
Qian Liu(Southeast University), Kongming Wu(Shanxi Medical University)
Cited by 125
Related Papers
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
|Molecular Cancer|2022|1.4k
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
|Molecular Cancer|2022|458
Chimeric antigen receptor T cells: a novel therapy for solid tumors
|Journal of Hematology & Oncology|2017|306
Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity
|Molecular Cancer|2019|266